27 results on '"Lee, W.C."'
Search Results
2. Real-World Treatment Behavior Among Patients With Dupuytren’s Contracture: A Health Insurance Claims-Based Analysis
3. Nebibe Varol
4. Mathematical Simulations Of Alogliptin-Pioglitazone-Treated Patients Meeting Quality Assurance Hba1c Threshold Requirements
5. Real World Outcomes in Type 2 Diabetes: Lower Cost of Treating Patients to A1c<7% with Liraglutide Versus Exenatide
6. GLP1 and Insulin Glargine Treatment Patterns Among Type 2 Diabetes Patients in Major EU Markets
7. The Experience Of Caring For Children With Hemophilia: Cross-Sectional Study Of Caregivers In The United States
8. Cost savings associated with faster bleeding resolution in the inpatient treatment of hemophilia with inhibitors for the United States: rFVIIa versus pd-aPCC
9. PND9 Huntington's Disease (HD) Direct Medical Costs: A Retrospective Claims Database Analysis
10. PSY15 Lifetime Impact of On-Demand Treatment Options on Bleeding, Hospitalization, and QOl in Italian Hemophilia Patients With Inhibitors
11. PSY29 Lifetime Impact on Bleeding Episodes and Hospitalization of On-Demand Treatment Options in French Hemophilia Patients With Inhibitors
12. PDB50 Long-Term Clinical and Economic Benefit Associated with Liraglutide Versus Sitagliptin Therapy When Added to Metformin in the Treatment of Type 2 Diabetes: a Core Diabetes Model Study
13. PSY16 Cost and Quality of Life Benefits of Faster Bleed Resolution with an Rfviia Analogue: a Mathematical Simulation Study for the German Population
14. PSY45 CHARACTERISTICS OF CAREGIVERS AND THEIR EXPERIENCE ASSOCIATED WITH CONGENITAL HEMOPHILIA OF INHIBITOR PATIENTS
15. PDB144 - Mathematical Simulations Of Alogliptin-Pioglitazone-Treated Patients Meeting Quality Assurance Hba1c Threshold Requirements
16. PDB129 - Nebibe Varol
17. PMS75 - Real-World Treatment Behavior Among Patients With Dupuytren’s Contracture: A Health Insurance Claims-Based Analysis
18. PDB127 - GLP1 and Insulin Glargine Treatment Patterns Among Type 2 Diabetes Patients in Major EU Markets
19. PDB43 - Real World Outcomes in Type 2 Diabetes: Lower Cost of Treating Patients to A1c
20. PSY27 - Cost savings associated with faster bleeding resolution in the inpatient treatment of hemophilia with inhibitors for the United States: rFVIIa versus pd-aPCC
21. PIH35 - The Experience Of Caring For Children With Hemophilia: Cross-Sectional Study Of Caregivers In The United States
22. PDB144 Mathematical Simulations Of Alogliptin-Pioglitazone-Treated Patients Meeting Quality Assurance Hba1c Threshold Requirements
23. PDB129 Nebibe Varol
24. PDB127 GLP1 and Insulin Glargine Treatment Patterns Among Type 2 Diabetes Patients in Major EU Markets
25. PSY27 Cost savings associated with faster bleeding resolution in the inpatient treatment of hemophilia with inhibitors for the United States: rFVIIa versus pd-aPCC
26. PDB43 Real World Outcomes in Type 2 Diabetes: Lower Cost of Treating Patients to A1c<7% with Liraglutide Versus Exenatide
27. PMS75 Real-World Treatment Behavior Among Patients With Dupuytren’s Contracture: A Health Insurance Claims-Based Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.